From 2012 to 2022, the pharmaceutical goods market size value per capita in South Korea demonstrated consistent growth, starting at 11.83 and peaking at 19.88 in 2021. This trajectory reflects an underlying upward trend with occasional fluctuations.
Year-on-year variations for the last two years indicated a decrease, standing at -2.12% from 2021 to 2022. Over the previous five years, the compound annual growth rate (CAGR) was 2.94%—an indicator of robust market expansion despite some volatility in recent years.
Looking into the future, key trends to watch include the impact of emerging healthcare technologies, demographic changes such as an aging population, and the regulatory landscape concerning pharmaceutical pricing and reimbursement. These factors are expected to influence market dynamics and demand patterns in South Korea's pharmaceutical sector.
| # | 41 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Norway | 44.82 | 2023 | View data | ||
| 2 | 2 Australia | 41.26 | 2023 | View data | ||
| 3 | 3 Germany | 40.08 | 2023 | View data | ||
| 4 | 4 Switzerland | 38.82 | 2023 | View data | ||
| 5 | 5 Austria | 38.7 | 2023 | View data | ||
| 18 | 18 Slovakia | 21.56 | 2023 | View data | ||
| 19 | 19 Finland | 20.59 | 2023 | View data | ||
| 20 | 20 South Korea | 20.12 | 2023 | |||
| 21 | 21 Greece | 19.86 | 2023 | View data | ||
| 22 | 22 Sweden | 19.59 | 2023 | View data | ||
